会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SANDWICH ASSAY FOR IMMUNOSUPPRESSANT DRUGS
    • 用于免疫抑制剂的三明治测定
    • US20130236918A1
    • 2013-09-12
    • US13413925
    • 2012-03-07
    • Tie Quan Wei
    • Tie Quan Wei
    • G01N33/566
    • G01N33/9493G01N2333/36
    • Methods are disclosed for determining an immunosuppressant drug in a sample suspected of containing an immunosuppressant drug. The method includes providing in combination in a medium the sample, a first monoclonal antibody for the immunosuppressant drug, and a second monoclonal antibody for the immunosuppressant drug. The second monoclonal antibody binds to a portion of the immunosuppressant drug other than the portion to which the first monoclonal antibody binds to the immunosuppressant drug. The medium is incubated under conditions for binding of the first monoclonal antibody and the second monoclonal antibody to the immunosuppressant drug. The medium is examined for the presence of an immunocomplex comprising the immunosuppressant drug, the first monoclonal antibody and the second monoclonal antibody. The presence and/or amount of the immunocomplex indicates the presence and/or amount of the immunosuppressant drug in the sample.
    • 公开了用于确定怀疑含有免疫抑制剂药物的样品中的免疫抑制剂药物的方法。 该方法包括在培养基中组合提供样品,用于免疫抑制剂药物的第一单克隆抗体和用于免疫抑制剂药物的第二单克隆抗体。 第二单克隆抗体结合一部分免疫抑制剂药物,而不是第一单克隆抗体与免疫抑制剂药物结合的部分。 将培养基在第一单克隆抗体和第二单克隆抗体与免疫抑制剂药物结合的条件下孵育。 检查介质是否存在包含免疫抑制剂药物,第一单克隆抗体和第二单克隆抗体的免疫复合物。 免疫复合物的存在和/或量表示样品中免疫抑制剂药物的存在和/或量。
    • 2. 发明申请
    • DETECTION OF FALSE RESULTS IN ASSAYS
    • 检测结果在测试中
    • US20100240073A1
    • 2010-09-23
    • US12409302
    • 2009-03-23
    • Tie Quan Wei
    • Tie Quan Wei
    • G01N33/53
    • G01N33/9493Y10T436/106664Y10T436/107497Y10T436/25125Y10T436/25375
    • Methods and reagents are disclosed for detecting a false result in an assay for determining a concentration of an analyte in a whole blood sample suspected of containing the analyte. The method comprises determining by means of the assay a concentration of the analyte utilizing a hemolyzed portion of the blood sample to obtain concentration value 1 and determining by means of the assay a concentration of the analyte utilizing a non-hemolyzed portion of the blood sample and multiplying the concentration times a hematocrit factor to obtain concentration value 2. A ratio of concentration value 1 divided by concentration value 2 is determined and is compared to a predetermined ratio of known reliability. If the ratio is less than the predetermined ratio, a false result is indicated.
    • 公开了用于在用于确定怀疑含有分析物的全血样品中的分析物的浓度的测定中检测假结果的方法和试剂。 该方法包括通过测定方法测定分析物的浓度,利用血液样品的溶血部分获得浓度值1,并通过测定法确定分析物的浓度,利用血液样品的非溶血部分, 将浓度乘以血细胞比容因子以获得浓度值2.确定浓度值1除以浓度值2的比例,并将其与已知可靠性的预定比率进行比较。 如果该比例小于预定比率,则指出错误结果。
    • 4. 发明授权
    • Sandwich assay for immunosuppressant drugs
    • 免疫抑制药物的三明治测定
    • US08586322B2
    • 2013-11-19
    • US13413925
    • 2012-03-07
    • Tie Quan Wei
    • Tie Quan Wei
    • G01N33/53G01N33/553
    • G01N33/9493G01N2333/36
    • Methods are disclosed for determining an immunosuppressant drug in a sample suspected of containing an immunosuppressant drug. The method includes providing in combination in a medium the sample, a first monoclonal antibody for the immunosuppressant drug, and a second monoclonal antibody for the immunosuppressant drug. The second monoclonal antibody binds to a portion of the immunosuppressant drug other than the portion to which the first monoclonal antibody binds to the immunosuppressant drug. The medium is incubated under conditions for binding of the first monoclonal antibody and the second monoclonal antibody to the immunosuppressant drug. The medium is examined for the presence of an immunocomplex comprising the immunosuppressant drug, the first monoclonal antibody and the second monoclonal antibody. The presence and/or amount of the immunocomplex indicates the presence and/or amount of the immunosuppressant drug in the sample.
    • 公开了用于确定怀疑含有免疫抑制剂药物的样品中的免疫抑制剂药物的方法。 该方法包括在培养基中组合提供样品,用于免疫抑制剂药物的第一单克隆抗体和用于免疫抑制剂药物的第二单克隆抗体。 第二单克隆抗体结合一部分免疫抑制剂药物,而不是第一单克隆抗体与免疫抑制剂药物结合的部分。 将培养基在第一单克隆抗体和第二单克隆抗体与免疫抑制剂药物结合的条件下孵育。 检查介质是否存在包含免疫抑制剂药物,第一单克隆抗体和第二单克隆抗体的免疫复合物。 免疫复合物的存在和/或量表示样品中免疫抑制剂药物的存在和/或量。
    • 5. 发明申请
    • DETERMINATION OF TOTAL ANALYTE CONCENTRATION
    • 总分析浓度的确定
    • US20130295592A1
    • 2013-11-07
    • US13465574
    • 2012-05-07
    • Tie Quan Wei
    • Tie Quan Wei
    • G01N21/76G01N33/53G06F19/00G01N21/64
    • G01N33/5306G01N21/6428G01N21/76G01N33/9493G06F19/24
    • Methods and reagents are disclosed for determining a total amount of an analyte in an unknown sample suspected of containing the analyte in the presence of endogeneous interfering substances. The methods involve measuring an amount [Y] of the portion of the analyte in the unknown sample that is bound by endogeneous binding substances employing an assay for the analyte. An amount [Z] of analyte in the unknown sample that is not bound by endogeneous binding substances is determined by the formula: [Z]=a[Y]+b, wherein “a” and “b” are predetermined by conducting the assay on samples containing known amounts of the analyte but substantially free from endogeneous interfering substances. Adding [Y] and [Z] yields the total amount [X] of the analyte in the unknown sample.
    • 公开了用于确定在内分子干扰物质存在下怀疑含有分析物的未知样品中分析物的总量的方法和试剂。 所述方法涉及通过使用分析物的测定法来测量未知样品中被分析物结合的部分的量[Y]。 不结合未结合物质的未知样品中的分析物的量[Z]由下式确定:[Z] = a [Y] + b,其中“a”和“b”通过进行测定 在含有已知量的分析物但基本上不含内源干扰物质的样品上。 添加[Y]和[Z]得到未知样品中分析物的总量[X]。